Canada - TSX Venture Exchange - TSX-V:ZEN - CA98942X1024 - Common Stock
The current stock price of ZEN.CA is 1.08 CAD. In the past month the price decreased by -10.74%. In the past year, price decreased by -34.55%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BLCO.CA | BAUSCH + LOMB CORP | 36.77 | 7.94B | ||
| OTC.CA | OCUMETICS TECHNOLOGY CORP | N/A | 111.92M | ||
| COO.CA | OSTROM CLIMATE SOLUTIONS INC | N/A | 5.13M |
Zentek Ltd. engages in the research, development, and commercialization of graphene-based novel products. The company is headquartered in Guelph, Ontario and currently employs 17 full-time employees. The company went IPO on 2010-12-22. The firm is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The firm is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The firm has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The firm is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.
ZENTEK LTD
24 Corporate Ct
Guelph ONTARIO P7B 6M4 CA
CEO: Greg Fenton
Employees: 24
Phone: 18447309822
Zentek Ltd. engages in the research, development, and commercialization of graphene-based novel products. The company is headquartered in Guelph, Ontario and currently employs 17 full-time employees. The company went IPO on 2010-12-22. The firm is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The firm is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The firm has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The firm is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.
The current stock price of ZEN.CA is 1.08 CAD. The price increased by 5.88% in the last trading session.
ZEN.CA does not pay a dividend.
ZEN.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
ZENTEK LTD (ZEN.CA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
ZENTEK LTD (ZEN.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.09).
ZENTEK LTD (ZEN.CA) will report earnings on 2026-02-11.
ChartMill assigns a fundamental rating of 3 / 10 to ZEN.CA. The financial health of ZEN.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months ZEN.CA reported a non-GAAP Earnings per Share(EPS) of -0.09. The EPS increased by 22.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.88% | ||
| ROE | -63.26% | ||
| Debt/Equity | 0.12 |